Skip to main content

Juan Jose Gonzalez Lopez

I am a clinical microbiologist and I work in the Microbiology Department at the Vall d'Hebron University Hospital. I am also associate professor in the Department of Genetics and Microbiology at the Autonomous University of Barcelona and head of the Microbiology Research Group at the Vall d'Hebron Research Institute.

Institutions of which they are part

Head of group
Microbiology
Vall Hebron Institut de Recerca
Biologist
Microbiology
Cross-departmental services

Juan Jose Gonzalez Lopez

Institutions of which they are part

Head of group
Microbiology
Vall Hebron Institut de Recerca
Biologist
Microbiology
Cross-departmental services

I am a clinical microbiologist and I work in the Microbiology Department at the Vall d'Hebron University Hospital. I am also associate professor in the Department of Genetics and Microbiology at the Autonomous University of Barcelona and head of the Microbiology Research Group at the Vall d'Hebron Research Institute.

My professional work is divided into three fundamental lines which are assistance, teaching and research.

In terms of assistance, I have been working as a clinical microbiologist in the Microbiology Service since 2010 where I am currently leading the areas of bacterial identification and antibiograms.

Regarding the teaching aspect, I am a professor of the Degree of Medicine and the Degree of Microbiology at the Vall d'Hebron Campus of the Autonomous University of Barcelona. Likewise, I participate as a teacher in different master's degrees related to the field of microbiology and infectious diseases.

Regarding the research work, I am the head of the Microbiology Research Group at the Vall d'Hebron Research Institute. My research career has focused mainly on the study of the mechanisms of action and resistance to antimicrobials, on the molecular characterization of multidrug resistant bacterial populations and on the study of the mechanisms of bacterial pathogenicity.

Recently I have also started to work in new fields including the search for new therapeutic strategies against multidrug-resistant bacteria, the study of the populations and evolution of Bordetella pertussis and Neisseria meningitidis and the study of molecular mechanisms involved in sepsis, as well as in the development and validation of new diagnostic tools for infectious diseases.

Projects

CIBER Malalties Infeccioses

IP: Juan Jose Gonzalez Lopez
Collaborators: CIBER Malalties Infeccioses, María Nieves Larrosa Escartin, Oscar Len Abad, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Javier Gomis Rodriguez, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, CIBER Malalties Infeccioses, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 100500
Reference: CB21/13/00054
Duration: 01/01/2022 - 31/12/2022

PHITBAC - Biosensores nanofotónicos para el diagnóstico y gestión clínica de infecciones bacterianas en el punto de atención

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Ricard Ferrer Roca, Juan Carlos Ruiz Rodriguez, Alba Mir Cros, Claudia Gomariz Querol
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 115970
Reference: PLEC2021-007739
Duration: 01/10/2021 - 30/09/2024

Ministerio de Ciencia

Secuenciacio´n de nueva generacio´n para el estudio de la dina´mica poblacional, adaptacio´n e identificacio´n de nuevos anti´genos vacunales de B. pertussis y B. holmesii.

IP: Juan Jose Gonzalez Lopez
Collaborators: Albert Moreno Mingorance, Judit Álvarez González
Funding agency: Instituto de Salud Carlos III
Funding: 82400
Reference: FI19/00315
Duration: 01/01/2020 - 31/12/2023

Drug Discovery and repurposing of nucleoside analogues as promising new antibacterial drugs Descobriment de Fàrmacs i reutilització d'anàlegs de nucleòsids com a nous i prometedors fàrmacs antibacterians

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Maria Belén Viñado Perez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2018/LLAV/00043
Duration: 30/09/2019 - 15/09/2020

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Sandra Martinez Solà

Sandra Martinez Solà

Secretary
Director
Read more
Yáiza Nuñez Amela

Yáiza Nuñez Amela

Read more
Natalia Avani Da Silva

Natalia Avani Da Silva

Medium Grade Technician
Communication Unit
Communication Directorate
Read more
Rut Mas deles Valls Cierco

Rut Mas deles Valls Cierco

Research technician
Headache and Neurological Pain
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.